Nellist Mark, van den Heuvel Diana, Schluep Diane, Exalto Carla, Goedbloed Miriam, Maat-Kievit Anneke, van Essen Ton, van Spaendonck-Zwarts Karin, Jansen Floor, Helderman Paula, Bartalini Gabriella, Vierimaa Outi, Penttinen Maila, van den Ende Jenneke, van den Ouweland Ans, Halley Dicky
Department of Clinical Genetics, Erasmus Medical Centre, Rotterdam, The Netherlands.
Eur J Hum Genet. 2009 Mar;17(3):319-28. doi: 10.1038/ejhg.2008.170. Epub 2008 Oct 1.
Tuberous sclerosis complex (TSC) is an autosomal dominant disorder characterised by the development of hamartomas in a variety of organs and tissues. The disease is caused by mutations in either the TSC1 gene on chromosome 9q34 or the TSC2 gene on chromosome 16p13.3. The TSC1 and TSC2 gene products, TSC1 and TSC2, interact to form a protein complex that inhibits signal transduction to the downstream effectors of the mammalian target of rapamycin (mTOR). Here we investigate the effects of putative TSC1 missense mutations identified in individuals with signs and/or symptoms of TSC on TSC1-TSC2 complex formation and mTOR signalling. We show that specific amino-acid substitutions close to the N-terminal of TSC1 reduce steady-state levels of TSC1, resulting in the activation of mTOR signalling and leading to the symptoms of TSC.
结节性硬化症(TSC)是一种常染色体显性疾病,其特征是在多种器官和组织中形成错构瘤。该疾病由位于9号染色体q34上的TSC1基因或16号染色体p13.3上的TSC2基因突变引起。TSC1和TSC2基因产物TSC1和TSC2相互作用形成一种蛋白质复合物,该复合物抑制信号转导至雷帕霉素哺乳动物靶点(mTOR)的下游效应器。在此,我们研究了在有TSC体征和/或症状的个体中鉴定出的假定TSC1错义突变对TSC1-TSC2复合物形成和mTOR信号传导的影响。我们发现,靠近TSC1 N端的特定氨基酸取代会降低TSC1的稳态水平,导致mTOR信号传导激活并引发TSC症状。